UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053657
Receipt number R000061229
Scientific Title A phase II study of cisplatin short hydration without diuretics.
Date of disclosure of the study information 2024/02/26
Last modified on 2024/02/20 11:07:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study of cisplatin short hydration without diuretics.

Acronym

A phase II study of cisplatin short hydration without diuretics.

Scientific Title

A phase II study of cisplatin short hydration without diuretics.

Scientific Title:Acronym

A phase II study of cisplatin short hydration without diuretics.

Region

Japan


Condition

Condition

Chemotherapy naive thoracic malignancy

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy and safety of cisplatin short hydration without diuretics.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

The proportion of patients who did not observe a Grade 2 or higher creatinine increase after the first cycle(defined as elevation in creatinine, CTCAE Ver. 5.0, based on the upper limit of the normal range (ULN) for serum creatinine at each institute)

Key secondary outcomes

1)The proportion of patients without grade 2 or higher creatinine increase at end of cycle
2)The number of chemotherapy cycles
3)Response rate
4)The proportion of adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Without diuretics administration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Thoracic malignancy
2)Patients who are eligible for combination chemotherapy with cisplatin (60 mg/m2 or more) (including combination therapy with immune checkpoint inhibitors and molecular target therapy drugs, and chemoradiotherapy)
3)Previously untreated with cisplatin-based chemotherapy
4)Patients aged 20 to 74 years
5)ECOG PS 0-1
6)WBC > 3000, Neu > 1500, Hb > 9g/dL, PLT > 100000, AST < 100IU/L, ALT < 100IU/L, T-Bil < 1.5mg/dL, SpO2 > 95% (room air)
7)Creatinine is below the upper limit normal range and creatinine clearance is 60mL/min or more
8)Patients with sufficient oral intake
9)Patients who have given written informed consent

Key exclusion criteria

1)Severe recurrent laryngeal nerve palsy or mediastinal mass
2)Pericardial effusion, pleural effusion, or ascites, with accumulation of fluid to a degree that requires drainage
3)Symptomatic brain metastases
4)Spinal metastases requiring urgent radiation or surgical treatment
5)Heart failure, unstable angina, myocardial infarction, acute kidney disease(within the past 6 months)
6)Complicated by poorly controlled diabetes even with continuous insulin use
7)Active infection(excluding viral hepatitis)
8)Receiving continuous systemic steroid therapy
9)Psychosis or comorbid psychiatric symptoms
10)Deemed inappropriate by attending physician

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Kaoru
Middle name
Last name Kubota

Organization

Nippon Medical School Hospital

Division name

Department of Pulmonary Medicine and Oncology

Zip code

113-8603

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

TEL

0338222131

Email

kkubota@nms.ac.jp


Public contact

Name of contact person

1st name Tetsuya
Middle name
Last name Wako

Organization

Nippon Medical School Hospital

Division name

Department of Pharmacy Services

Zip code

1138603

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

TEL

0338222131

Homepage URL


Email

t-wako@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School Hospital Drug Institutional Review Board

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

Tel

0338222131

Email

inq-ccr@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本医科大学付属病院(東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

46

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 04 Day

Date of IRB

2020 Year 08 Month 20 Day

Anticipated trial start date

2019 Year 06 Month 01 Day

Last follow-up date

2023 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 20 Day

Last modified on

2024 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061229


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name